Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Relypsa
5301 Patrick Henry Drive
Santa Clara, CA 95054
Phone: 408-200-9500
www.relypsa.com

Relypsa, Inc. is a clinical-stage pharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is patiromer, a non-absorbed potassium binder for the treatment of hyperkalemia. Relypsa is pursuing the discovery of additional product candidates through use of its proprietary polymer platform.

Key Contact
Name
Gerrit Klaerner
Title
President
E-Mail
Funding Events

Date
Amount
Type
Investors
08/15/12 $80,000,000 Series C 5AM Ventures
Delphi Ventures
Mediphase Venture Partners
New Leaf Venture Partners
OrbiMed Advisors
Sibling Capital